Insight-As-A-Service (IAAS)

Turn Biological Complexity Into Clinical Actionability.

One integrated AI layer for Oncology, Immunology, and Cardiology that identifies, salvages, and recruits for your most critical assets.

The Integrated AI Layer

This Platform utilizes four interconnected pillars covering the entire drug lifecycle, with a core focus on Oncology, Immunology, and Cardiology:

Identifies new indications (repurposing), novel combinations, or next-generation molecule opportunities for shelved or existing assets by scanning biological and clinical data.

Indication Repurposing

Combination Discovery

A predictive platform (MVP phase) for Generic and Biosimilar players to forecast the probability of technical and regulatory success for "Out-of-Patent" pipelines.

Digital Twinning

Patient Stratification

Analyzes clinical trial design, endpoints, and patient populations to identify reasons for failure or hidden efficacy signals in underperforming trials.

Direct EMR Integration

Real-World Data Insights

Quantifiable Value for Global Pharma

We deliver measurable outcomes across the clinical development continuum, transforming R&D sunk costs into market leadership.

Asset Salvage

Identify responder sub-populations in failed trials using TrialFit®.

Acceleration

Identifies new indications and combination opportunities using DrugReboot™.

Portfolio Alpha

Rank generic/biosimilar candidates via DrugSuccess.Ai™.

Faster Enrollments

M+

Cost Avoidance

% +

Higher PTRS

24/7

Patient Monitoring

Request a Confidential
Portfolio Audit

Our computational biologists and oncologists will deliver a “Proof of Insight” dossier for your top asset.

First Name *

Last Name *

Work Email *

Primary Therapeutic Area Of Interest *

Notes / Specific Asset Target (Optional)

Turn Biological Complexity Into Clinical Actionability.

The Integrated AI Layer